Trombocytose
Publisert:
Sist revidert av:Silje Folven Barlindhaug
- Rokkam VR, Kotagiri R. Secondary thrombosis. Updated 2020 Aug 1. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2021 Jan
- Rokkam VR, Kotagiri R. Secondary thrombosis. Updated 2020 Aug 1. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2021 Jan. www.ncbi.nlm.nih.gov
- Bailey SE, Ukoumunne OC, et al. Clinical relevance of thrombocytosis in primary care: a prospective cohort study of cancer incidence using English electronic medical records and cancer registry data. Br J Gen Pract. 2017 Jun;67(659):e405-e413. doi:10.3399/bjgp17X691109. PubMed PMID: 28533199. PubMed
- Roaldsnes C, Holst R, Frederiksen H, Ghanima W. Myeloproliferative neoplasms: trends in incidence, prevalence and survival in Norway. Eur J Haematol. 2017 Jan;98(1):85-93. Epub 2016 Sep 4. PMID: 27500783.
- Tefferi A. Approach to the patient with thrombocytosis. UpToDate, last updated Jan 09, 2019. Siden besøkt 04.05.21 www.uptodate.com
- Mathur A, Samaranayake S, Storrar NP, Vickers MA. Investigating thrombocytosis published correction appears in BMJ. 2019 Dec 4;367:l4569. BMJ. 2019;366:l4183. PMID:31272949.
- Clarke C, Hamilton W, Price S, Bailey SE. Association of non-malignant diseases with thrombocytosis: a prospective cohort study in general practice. Br J Gen Pract. 2020 Nov 26;70(701):e852-e857. PMID: 33199294 PubMed
- Bailey SE, Ukoumunne OC, et al. How useful is thrombocytosis in predicting an underlying cancer in primary care? a systematic review. Fam Pract. 2017 Feb;34(1):4-10. doi: 10.1093/fampra/cmw100. Epub 2016 Sep 28. Review. PubMed PMID: 27681942. PubMed
- Silje Folven Barlindhaug, spesialist i allmennmedisin, redaktør NEL